Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels
about
Non-systemic drugs: a critical reviewAntidiarrheal efficacy and cellular mechanisms of a Thai herbal remedyNoninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral TherapyDesigning a broad-spectrum integrative approach for cancer prevention and treatment.Recent advances in pharmacological treatment of irritable bowel syndrome.Role of the Ca2+ -activated Cl- channels bestrophin and anoctamin in epithelial cells.Anoctamins.Crofelemer for the treatment of secretory diarrhea.Syntaxin 3 is necessary for cAMP- and cGMP-regulated exocytosis of CFTR: implications for enterotoxigenic diarrhea.Activation of the basolateral membrane Cl- conductance essential for electrogenic K+ secretion suppresses electrogenic Cl- secretion.Crofelemer: a review of its use in the management of non-infectious diarrhoea in adult patients with HIV/AIDS on antiretroviral therapy.Human Immunodeficiency Virus-Associated Diarrhea: Still an Issue in the Era of Antiretroviral Therapy.Antibacterial and antidiarrheal activities of plant products against enterotoxinogenic Escherichia coli.Safety surveillance of traditional Chinese medicine: current and futureEthnopharmacological Survey of Plants Used in the Traditional Treatment of Gastrointestinal Pain, Inflammation and Diarrhea in Africa: Future Perspectives for Integration into Modern Medicine.Drug-induced secretory diarrhea: A role for CFTR.Convective washout reduces the antidiarrheal efficacy of enterocyte surface-targeted antisecretory drugsSecretory diarrhoea: mechanisms and emerging therapies.Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDSChloride channel-targeted therapy for secretory diarrheasDiscovery and development of antisecretory drugs for treating diarrheal diseases.Crofelemer, a novel agent for treatment of secretory diarrhea.Developing novel antisecretory drugs to treat infectious diarrhea.Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas.Calcium-activated chloride channels in the corpus cavernosum: recent developments and future of a key cellular component of the erectile process.Agents that act luminally to treat diarrhoea and constipation.Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons.Natural product and natural product derived drugs in clinical trials.Discovery of functional antibodies targeting ion channels.Emerging drug for diarrhea predominant irritable bowel syndrome.Drug discovery approaches to irritable bowel syndrome.Crofelemer for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy.The Botanical Drug Substance Crofelemer as a Model System for Comparative Characterization of Complex Mixture Drugs.Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome.Pathogen-induced secretory diarrhea and its prevention.A multiple biomarker assay for quality assessment of botanical drugs using a versatile microfluidic chip.The contribution of mechanistic understanding to phenotypic screening for first-in-class medicines.Molecular ion index assisted comprehensive profiling of B-type oligomeric proanthocyanidins in rhubarb by high performance liquid chromatography-tandem mass spectrometry.Dacomitinib-induced diarrhea: Targeting chloride secretion with crofelemer.Inability to reduce morbidity of diarrhea by ORS: Can we design a better therapy?
P2860
Q26863371-95E8EDA1-C649-40F6-890E-B7F3A6350A86Q28539765-5BED5075-3254-440A-9ED3-FC0E123BF6A8Q30609066-5D3B03DA-5806-4824-94A5-59378090A29BQ30736359-6AF27CBE-16D6-4039-83C1-E7CA7B76DCB2Q33958853-D95995F4-2E94-47D3-BE48-132FD9C5E0BCQ34157053-2B410306-6977-4B92-AA69-E9F24251EC66Q34186977-9071EC8B-303E-4C4F-91BB-6422F62DED97Q34239002-2AE16962-FBEA-48CF-81F4-31DA4B517AE5Q34426451-37C90BF9-BBA3-4D22-94EF-661D897960ECQ34586656-DAF94674-656B-40D7-84BD-D212D1C9818AQ34653691-3DC8EEA0-4B13-4BB5-890D-1875DABAEF43Q34668617-41A62AFE-7250-4B45-BC79-4C89B6D23ECEQ35037922-4AD94215-234C-41EE-B0F1-6B92484BA6DDQ35142633-6B932725-5A55-4B67-B6B3-EC08474A76FCQ35830360-E4127E6B-FC7D-4B59-B1B7-05C5301B5531Q36385185-BC34E59F-B32B-491C-A483-9AC5C29C89D0Q36568476-B701081B-B1FE-4C4D-A3A2-EF809AC40064Q36673563-8925C734-38C7-4205-AF81-45D2FCF37973Q37042269-5766CDA4-57C6-478D-8B8E-C3BDDAD34A49Q37472982-3C271048-660F-4188-A045-A24291F93083Q37604943-4168C697-1057-48FF-BE19-86237BE51FD9Q37730305-3C5AEACD-B680-4C58-8AF3-57265FB0644EQ37920905-ADCC8C86-2801-4E2B-B32E-337AD8093A07Q37990948-2A871553-0B3A-4147-80E5-D37BDE9A1B7BQ38020328-ACE1366D-DDAE-42D0-A7DB-A47C420ECF98Q38040321-5829AC58-3902-4B6F-8BAD-26DF8D2606B9Q38144148-5BD70AAA-2B26-4060-AC8C-2A79B1A50D1EQ38247457-3BBA8F91-98B4-4D2F-A33A-89F58E250283Q38282832-82A1EF2A-C21F-4467-AE8A-076E0A75B448Q38366814-B460276A-8435-4FC5-AAE5-1A69770F887BQ38550878-6C81DA38-2091-49AA-A235-05A40144B496Q38620255-DCC247AA-4F45-49BC-8B26-FB94767A6BCEQ38661672-91D8FB30-3EB5-4679-8522-C7275317A059Q38856699-F9E08B68-321B-4078-8F52-5E1B2BC00B09Q38912737-79661065-8D30-41D6-B8E5-97FF22131D21Q42363689-86F943F4-7F15-4A04-8FA8-030E429CF9F6Q44143302-01770BC8-42E0-45EF-AA59-FE0227694F24Q46587244-74174CAA-F34C-40D9-AFE8-93F1AEF90A23Q47786578-561E9FF9-CFC7-4D7E-989A-45842FDC3591Q47821614-A545B2D8-DE85-45DA-B742-200E321F49DF
P2860
Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Crofelemer, an antisecretory a ...... t intestinal chloride channels
@ast
Crofelemer, an antisecretory a ...... t intestinal chloride channels
@en
Crofelemer, an antisecretory a ...... intestinal chloride channels.
@nl
type
label
Crofelemer, an antisecretory a ...... t intestinal chloride channels
@ast
Crofelemer, an antisecretory a ...... t intestinal chloride channels
@en
Crofelemer, an antisecretory a ...... intestinal chloride channels.
@nl
prefLabel
Crofelemer, an antisecretory a ...... t intestinal chloride channels
@ast
Crofelemer, an antisecretory a ...... t intestinal chloride channels
@en
Crofelemer, an antisecretory a ...... intestinal chloride channels.
@nl
P2093
P2860
P356
P1476
Crofelemer, an antisecretory a ...... t intestinal chloride channels
@en
P2093
A S Verkman
Lukmanee Tradtrantip
Wan Namkung
P2860
P356
10.1124/MOL.109.061051
P577
2009-10-06T00:00:00Z